Cognition Therapeutics (CGTX) Earnings Date & Reports

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CGTX is expected to report earnings to fall 44.64% to -7 cents per share on August 12

Cognition Therapeutics CGTX Stock Earnings Reports

Q2'25

Est.

$-0.08

Q1'25

Missed

by $0.03

Q4'24

Missed

by $0.02

Q3'24

Missed

by $0.05

Q2'24

Beat

by $0.06

The last earnings report on May 07 showed earnings per share of -14 cents, missing the estimate of -10 cents. With 2.62M shares outstanding, the current market capitalization sits at 18.67M.

View a ticker or compare two or three

Compare

CGTX